Reimbursed Care Access in Dominica

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Relevant Dominican legislation places control on illicit psychoactive substances; national drug control texts (e.g., the Drugs Misuse Act as catalogued by UNODC) are the primary legal instruments used to criminalize possession, supply and cultivation. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. MDMA and related empathogens are treated as prohibited under Dominica’s drug-control framework; there is no public record of MDMA being authorized for medical or reimbursed use. #

Esketamine (marketed internationally as Spravato) is not commonly registered or reimbursed in small Caribbean health systems unless specifically imported or procured by private hospitals; there is no public national regulatory listing or official reimbursement policy for esketamine identified for Dominica in available government/regulatory sources. Ketamine is recognized and used as an anesthetic globally, but the specialized intranasal esketamine product requires explicit national registration and certified clinic pathways where authorised — no evidence of such a registered pathway for Spravato in Dominica was found in national sources or regional regulatory listings. For context, ketamine is listed on the World Health Organization’s essential medicines lists for anesthesia. #; #.

Ketamine is a legally recognized medicinal anesthetic and analgesic agent in global practice and appears in international essential-medicines guidance, so its medical use for anesthesia in clinical settings is the accepted pathway in Dominica as in most health systems; this is consistent with WHO essential-medicines listings for ketamine. #.

However, the use of ketamine for psychiatric indications (intravenous/subanesthetic infusions for depression) is an off-label practice internationally and typically is not publicly reimbursed unless a national reimbursement policy specifically covers it. There is no public record of Dominica having a national reimbursement program, formal clinical guidance or a certified clinic network that reimburses ketamine for treatment-resistant depression; therefore psychiatric/off-label ketamine treatment in Dominica would generally be provided through private clinics at patient expense or within formally approved clinical research. The national drug-control framework still controls distribution and requires ketamine be handled within medical supply chains. #; #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Dimethyltryptamine (DMT) and its derivatives are covered by the broad prohibitions in Dominica’s drug-control legislation; no national medical licensing pathway or reimbursement for DMT therapy has been identified. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no indication of legal medical access or reimbursement for 5‑MeO‑DMT in Dominica. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Ibogaine is not recognized in Dominica’s public medical-reimbursement frameworks and has no authorized therapeutic program in-country. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Because ayahuasca contains DMT and related controlled tryptamines, its use and distribution are subject to the same prohibitions; no authorized medical or reimbursed use was identified. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mescaline and peyote-related substances fall under prohibitions in Dominica’s drug-control framework; no public medical-use or reimbursement pathways exist. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Phenethylamine-class substituted psychedelics (2C-series) are covered by broad prohibitions in Dominica’s drug laws; no medical authorization or reimbursement was located. #